Financial Performance - The company recorded no revenue for the six months ended June 30, 2021, compared to HKD 72 million in the same period of 2020, with a consolidated loss attributable to owners of HKD 99 million, down from HKD 314 million in 2020 [5]. - For the six months ended June 30, 2021, the company reported a total revenue of HKD 0, compared to HKD 7,173,000 for the same period in 2020, representing a decline of 100% [26]. - The company recorded a gross profit of HKD 0, down from HKD 3,894,000 in the previous year, reflecting a complete halt in revenue generation [26]. - The company reported a loss before tax of HKD (9,942,000), an improvement from a loss of HKD (31,444,000) in the prior year, indicating a reduction in losses by approximately 68% [26]. - The total comprehensive loss for the period was HKD (9,942,000), compared to HKD (31,443,000) in the previous year, marking a significant decrease in overall losses [26]. - The company recorded a net loss of HKD 9,942,000 for the six months ended June 30, 2021, compared to a loss of HKD 29,860,000 in the same period of 2020, indicating a significant improvement [36]. - The company reported a total cash outflow from operating activities of HKD 1,723,000 for the six months ended June 30, 2021, an improvement from HKD 3,945,000 in the previous year [33]. Assets and Liabilities - Total assets and net liabilities as of June 30, 2021, were HKD 127 million and HKD 316.8 million, respectively, compared to HKD 273 million and HKD 316.3 million as of December 31, 2020 [6]. - As of June 30, 2021, total assets were HKD 10,874,000, down from HKD 19,022,000 at the end of 2020, reflecting a decline of approximately 43% [28]. - The company's total liabilities increased to HKD 316,836,000 from HKD 316,303,000, indicating a slight increase in financial obligations [28]. - The total liabilities as of June 30, 2021, amounted to HKD 316,800,000, with current liabilities at HKD 234,400,000 [36]. - The company has a total equity attributable to owners of HKD (301,017,000) as of June 30, 2021, reflecting a decrease from the previous period [36]. - The company recorded a total asset value of HKD 12,743,000 as of June 30, 2021, compared to HKD 27,297,000 as of December 31, 2020, indicating a decrease in total assets [42]. - The company reported a total liability of HKD 329,579,000 as of June 30, 2021, compared to HKD 343,600,000 as of December 31, 2020, reflecting a reduction in total liabilities [42]. Cash and Financing - The company's cash and bank balances were HKD 4 million as of June 30, 2021, down from HKD 11 million as of December 31, 2020, with a current ratio of 0.04 compared to 0.08 in the previous period [6]. - Cash and cash equivalents decreased to HKD 372,000 at the end of June 2021, down from HKD 2,191,000 at the end of June 2020 [33]. - The company has obtained financing of HKD 8,000,000 and HKD 12,000,000 from investors to support its operational costs and business activities [37]. - Interest expenses for the six months ended June 30, 2021, decreased to HKD 8,236,000 from HKD 9,968,000 in the same period of 2020, showing a reduction in financing costs [46]. - The company's borrowings increased to HKD 205,054,000 as of June 30, 2021, from HKD 201,630,000 as of December 31, 2020, reflecting a slight increase in debt levels [52]. Operational Activities - The company has been actively seeking business opportunities to enhance long-term shareholder value despite challenges from the COVID-19 pandemic and other geopolitical factors [7]. - No significant capital raising activities were conducted during the six months ended June 30, 2021 [8]. - There were no major investments, acquisitions, or disposals during the reporting period [9]. - The company has no significant assets pledged as collateral as of June 30, 2021 [10]. - The total number of employees as of June 30, 2021, was 4, with compensation based on performance and market levels [14]. - The company remains committed to strict financial management and is exploring new business opportunities for profit growth and stakeholder value enhancement [7]. - The company faced a liquidation of a subsidiary in March 2021, which was finalized in July 2021, impacting its operational structure [55]. Segment Performance - The medical and health business segment reported no revenue for the six months ended June 30, 2021, compared to HKD 7,173,000 in the same period of 2020 [38]. - The company has not reported any segment revenue for its medical and health lifestyle business for the current period [40]. - The company is focusing on developing its medical and health lifestyle business to improve cash flow [37]. Expenses and Income - The cost of goods sold and services for the same period was HKD (0), while it was HKD (3,279,000) in 2020, indicating a significant reduction in operational costs [26]. - Other income, gains, and losses increased to HKD 9,127,000 from HKD 2,992,000, showing a growth of approximately 205% [26]. - Administrative expenses decreased to HKD (10,833,000) from HKD (22,590,000), a reduction of about 52% [26]. - The company had no share options or share awards granted during the six months ended June 30, 2021, maintaining a status quo in equity compensation plans [20][21]. - The company has no interim dividend declared for the six months ended June 30, 2021, consistent with the previous year [48].
京玖康疗(00648) - 2023 - 中期财报